Research Beam added a report on “EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2024” Enquiry about report: http://www.researchbeam.com/epicast-report-type-2-diabetes-epidemiology-forecast-to-2024-market/enquire-about-report

1. EpiCast Report: Type 2
Diabetes - Epidemiology
Forecast to 2024
TELEPHONE: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com

2. Report Overview
Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public
health problem globally, with an estimated 387 million people living with diabetes worldwide. At least 90%
of all diabetes cases are T2D. Risk factors for T2D are broadly categorized as modifiable and non-
modifiable risk factors. Lifestyle factors such as obesity, physical inactivity and dietary habits are
modifiable risk factors and therefore it can be controlled or prevented. Non-modifiable risk factors, such
as family history and advancing age, can also put a person at high risk for developing the disease. T2D is
also associated with several comorbidities, such as CKD, CVD, hypertension, and dyslipidemia, which can
worsen the quality of life of the patient, and can lead to poor therapeutic outcomes.
Scope
The Type 2 Diabetes (T2D) EpiCast Report provides an overview of the risk factors, comorbidities, and
global trends for T2D in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan,
China, and India). It includes a 10-year epidemiological forecast of the one-year prevalent cases of T2D
segmented by sex, age (in five-year increments beginning at 20 years and ending at =85 years), and
comorbidities in these markets.
The T2D epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of
disease trends in the 10MM.
Read More At : http://www.researchbeam.com/epicast-report-type-2-diabetes-epidemiology-forecast-
to-2024-market

3. Table of Content
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.3 Global Trends 12
3.3.1 US 12
3.3.2 5EU 13
3.3.3 Japan 13
3.3.4 China and India 14
3.4 Forecast Methodology 15
3.4.1 Sources Used for Diagnosed Prevalence of T2D 20
3.4.2 Sources Not Used 31
3.4.3 Forecast Assumptions and Methods, Diagnosed Prevalent Cases of T2D 32
3.5 Epidemiological Forecast for T2D (2014-2024) 43
3.5.1 Diagnosed Prevalent Cases of T2D 43
3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D 45
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D 47

4. Table of Content
3.5.4 Age-Standardized Diagnosed Prevalence of T2D 49
3.5.5 Prevalent Cases of CKD Among Diagnosed T2D Cases 51
3.5.6 Prevalent Cases of CVD Among Diagnosed T2D Cases 51
3.5.7 Prevalent Cases of Overweight/Obesity Among Diagnosed T2D Cases 52
3.5.8 Prevalent Cases of Hypertension Among Diagnosed T2D Cases 53
3.5.9 Prevalent Cases of Dyslipidemia Among Diagnosed T2D Cases 54
3.6 Discussion 55
3.6.1 Epidemiological Forecast Insight 55
3.6.2 Limitations of the Analysis 56
3.6.3 Strengths of the Analysis 56
4 Appendix 58
4.1 Bibliography 58
4.2 About the Authors 65
4.2.1 Epidemiologists 65
4.2.2 Reviewers 65
4.2.3 Global Director of Therapy Analysis and Epidemiology 66
4.2.4 Global Head of Healthcare 67
4.3 About GlobalData 68
4.4 About EpiCast 68
4.5 Disclaimer 69
Enquire At : http://www.researchbeam.com/epicast-report-type-2-diabetes-epidemiology-forecast-to-
2024-market/enquire-about-report

5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/epicast-report-type-2-diabetes-epidemiology-forecast-to-2024-
market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com